Functional analysis of genome-wide dataset from 17000 individuals identifies multiple candidate malaria resistance genes enriched in malaria pathogenic pathways

Delesa Damena, Francis Agamah, Peter O. Kimathi, Ntumba E. Kabongo, Hundaol Girma, Wonderful T. Choga, Lemu Golassa, Emile R. Chimusa
doi: https://doi.org/10.1101/2020.08.15.20175471

Abstract

Recent genome-wide association studies (GWASs) of severe malaria have identified several association variants. However, much about the underlying biological functions are yet to be discovered. Here, we systematically predicted plausible candidate genes and pathways from functional analysis of severe malaria resistance GWAS summary statistics (N = 17,000) metaanalyzed across eleven populations in malaria endemic regions. We applied positional mapping, expression quantitative trait locus (eQTL), chromatin interaction mapping and gene-based association analyses to identify candidate severe malaria resistance genes. We performed network and pathway analyses to investigate their shared biological functions. We further applied rare variant analysis to raw GWAS datasets (N = 11,000) of three malaria endemic populations including Kenya, Malawi and Gambia and performed various population genetic structures of the identified genes in the three populations and global populations.

Our functional mapping analysis identified 57 genes located in the known malaria genomic loci while our gene-based GWAS analysis identified additional 125 genes across the genome. The identified genes were significantly enriched in malaria pathogenic pathways including multiple overlapping pathways in erythrocyte-related functions, blood coagulations, ion channels, adhesion molecules, membrane signaling elements and neuronal systems. Our population genetic analysis revealed that the minor allele frequencies (MAF) of the single nucleotide polymorphisms (SNPs) residing in the identified genes are generally higher in the three malaria endemic populations compared to global populations. Overall, our results suggest that severe malaria resistance trait is attributed to multiple genes; highlighting the possibility of harnessing new malaria therapeutics that can simultaneously target multiple malaria protective host molecular pathways.

Introduction

Malaria is still one of the global health problems with approximately 228 million cases and 405, 000 deaths in 2018 (1). African countries disproportionately carry the global burden of malaria accounting for 93% and 94% of cases and deaths, respectively (1). P. falciparum malaria is still one of the leading causes of child mortality in endemic regions, particularly in sub-Saharan Africa. According to the World Health Organization (WHO), malaria killed about 285,000 under five children in 2016 (2). About 10–20% of children who recover from severe malaria develop neurological sequalae and sub-optimal neuronal development (3). Severe malaria (SM) is defined as demonstration of asexual forms of the malaria parasites in the blood of a patient with a potentially fatal manifestation or complication of malaria in whom other diagnosis have been excluded (4). The SM complications include rapid progression to severe malarial anaemia (SMA), hypoglycaemia, cerebral malaria(CM), acidosis and death (4).

The global malaria eradication program, accelerated by the WHO led Roll Back Malaria (RBM) partnership, is largely focusing on scaling up the coverage of the available intervention strategies such as the distribution of long-lasting insecticide treated nets (LLINS), indoor residual insecticide spraying, intermittent treatment for pregnant women in high transmission settings and rapid diagnosis and effective treatments using artemisinin-based combination therapies (ACTs) (5). This led to the significant decline of malaria burden in many parts of the endemic regions. Despite the successes gained in reducing the global burden of malaria, the progress towards global malaria elimination is challenged by wide arrays of problems including decreased funding, lack of political commitments in some countries, emergence of drug resistant parasites and insecticide resistant mosquitoes and lack of effective vaccine among others (6).

P. falciparum has a complex life cycle alternate between vertebrate and female Anopheles mosquito. During its blood meal, the infected mosquitoes inoculates the transmissive form the parasite, the sporozoites, in to human skin. From the skin the sporozoites enter in to the blood circulation or up-taken by the lymphatic system and invade liver (7). After maturation, the parasite buds off the hepatocytes and released in to the circulation in the form of merozomes containing hundreds of thousands of merozoites that infect erythrocytes (7). The erythrocyte stage also called blood stage lifecycle is complex multi-step process that involve repeated invasion, growth, replication and egress events (8). To create favourable environment for its survival and growth, the parasite remodels the infected erythrocyte (IE). The remodelling events include creation of a parasitophorous vacuolar membrane (PVM) that surrounds the parasite and modification of antigenic and structural properties of the IE by transporting a protein called P. falciparum erythrocyte membrane protein 1 (PfEMP1) to the surface (8). The clinical symptoms of the SM have been linked to the blood stage life cycle (8).

Even though SM is one of the commonest reasons for admission to hospital and is a major cause of hospital death in children aged 1–5 years in endemic areas, it constitutes only a small subset (1–2%) of the infected children as the majority of malaria infections is mild (9). It has been shown that such clinical variations is partly attributable to human genetic factors (10, 11). Thus, a comprehensive understanding of the human genetic causes of variation in malaria clinical outcome may potentially provide clues to design new intervention strategies such as therapeutics and vaccines which can facilitate the global malaria eradication program (12, 13).

Aiming at shedding more light to the genetic basis of severe P. falciparum malaria, several genome-wide association studies (GWASs) have been conducted in diverse malaria endemic populations over the last decade (14–18). The GWASs have replicated some of the well-known malaria susceptibility genomic risk loci including sickle cell (HBB) and ABO blood group loci and identified new variants in ATP2B4 and Glycophorin regions (14–18). Due to the single-marker testing approach commonly used, single SNP-based GWASs may miss candidate variants with weak genetic effects and therefore, combining all effects from multiple variants within a gene and deconvoluting the interactions between genes underlying the malaria resistance trait may provide important insights in to underlying genetics (19). Today, a number of gene-based and pathway-level statistical analytic methods have recently been developed and successfully implemented in complex disease studies (20–23). These methods integrate functional information from advanced biological databases including the Genotype-Tissue Expression (GTEx)(24), Encyclopedia of DNA Elements (ENCODE) (25), Roadmap Epigenomics Project (26) and chromatin interaction information (27). Owing to the fact that direct functional follow-up of several candidate causal variants and genes is expensive, application of such computational method to prioritize genes and their respective biological pathways are proven to be useful in complex diseases studies (20). Furthermore, gene and gene-set analysis can improve the study power by aggregating the joint effects of weakly associated markers, a common challenge in a polygenic trait studies (28).

Here, we implement several gene-set, pathway and network analytic methods on summary statistics of severe malaria GWAS from 17,000 individuals meta-analysed across eleven populations and systematically predicted plausible genes and pathways. We further performed rare variant analysis on raw GWAS dataset (N = ∼11,000) of Kenya, Gambia and Malawi populations. Finally, we performed population genetic structure analysis of the identified genes in the three malaria endemic countries and across global populations. Established over the course of long coevolution time, blood stage life cycle of the parasite constitutes the most extensive interplay between host and parasite genomes which leads to the clinical symptoms of SM. Therefore, our results suggest that severe malaria resistance is polygenic and attributed to multiple genes aggregated in pathogenic pathways linked to the erythrocyte stage lifecycle of P. falciparum.

Results

Functional mapping and annotations

We applied three functional mapping strategies to the severe malaria GWAS summary statistics (N = 17,000 samples, ∼17 million SNPs) meta-analysed across 11 malaria endemic populations in Africa, Asia and Oceania (see Material and Methods). We identified 19 lead SNPs out of 69 significant SNPs across 6 genomic loci (Supplementary Data 1–3). The genomic locus was defined as the region that contain independent lead SNPs and nominally significant SNPs (p< 0.05) in linkage dis-equilibrium (LD) block with lead SNPs. An independent significant SNP was defined as a genome-wide significant SNP (P-value < 5e-8) within the genomic boundary of LD threshold of r2 > 0.6. Lead SNPs were selected from independent significant SNPs at LD threshold of r2 > 0.1. SNPs in close proximity (< 250 kb) were considered as a single locus and thus, each genomic locus can contain multiple independent significant SNPs and lead SNPs. These SNPs were significantly enriched in ncRNA-intronic, intronic, intergenic and ncRNA-exonic regions (Fig1.A).

Fig.1.
Fig.1.

A) Proportion of malaria resistance GWAS SNPs in different genomic annotation categories. B) The number of genes identified by each of the three functional mapping strategies including positional mapping, eQTL and chromatin interactions. The intersection sections of the circles depict the number overlapped genes between the respective mapping strategies.

Our functional mapping strategies yielded a total of 57 protein-coding genes (Table 1, Supplementary Data 4). These include 29, 23 and 14 genes identified by eQTL mapping, chromatin interaction mapping and positional mapping, respectively (Fig1.B). Two genes including ATP2B4 and HBD were identified by all the three gene mapping strategies while five genes including GYPB, HBG2, TRIM6-TRIM34, OR51F2 and TRIM68 were predicted by two of the three mapping strategies (Supplementary Data 4).

View this table:
Table 1. Fifty-seven severe malaria resistance candidate genes identified by eQTL mapping, chromatin interaction mapping and positional mapping strategies implemented in FUMA

The identified genes were enriched in five cytogenic positions including 11p15 (p = 2.65e-18), chr9q34 (p = 4.63e-9), chr4p31(p = 4.6e-8), chr1q32 (p = 2.6e-7), chr3q26 (p = 7.97e-4) (S1 Table). We noted that the majority (33%) of the identified genes were clustered on 11p15 (Fig 2). These include beta globin gene cluster: HBB, HBD, HBG1, HBG2 and HBE1; Tripartite motif-containing (TRIM) family genes including TRIM68, TRIM21; and genes involved in olfactory receptors and G protein-coupled signalling (GPCR) such as: CCKR OR51F2 and OR51L (Supplementary Table 1). About two third (13/19) of the genes in this locus are in eQTL and chromatin interactions (Supplementary Data 4 and Supplementary Fig 1).

All the implicated genes in chr9q34 locus are located outside the genomic risk locus and were identified by eQTL mapping (Supplementary Data 4, Supplementary Fig 2). These include surfeit gene cluster such as: SURF2, SURF4, MED22 and SURF6; a metalloprotease gene, ADAMTS13; and a gene encoding ORS blood group system coding gene (GBGT1). In the remaining enriched cytogenic positions, the known genes including ATP2B4 (chr1q32); FREM3, GYPE and GYPB (chr4p31) were replicated. Other notable genes include BTG2 a tumour suppressor gene on chr1q32 and B3GALNT1 on chr3q26 (Supplementary Data 4).

Fig. 2.
Fig. 2.

Regional plot of severe malaria susceptibility GWAS locus on chromosome 11. Non-GWAS-tagged SNPs are shown at the top of the plot as rectangles since they do not have a P-value from the GWAS. Prioritized genes are highlighted in red. eQTLs are plotted per gene and coloured based on tissue types. CADD score, RegulomeDB score and eQTLs, SNPs which are not mapped to any gene are coloured grey.

Candidate genes identified by gene-based GWAS analysis

Taking the polygenic nature of severe malaria resistance trait in to consideration (11), we applied a pathway scoring algorithm(Pascal) (22) method that aggregates all SNPs within a gene and capture polygenic effects at the gene level (see Material and Methods). The Pascal analysis replicated 13 genes that were identified by our functional annotation methods in malaria genomic risk loci (Supplementary Table 2) and identified 125 additional genes across the genome (Supplementary Data 5). The genes with top scores outside genomic risk loci include CSMD1 (p = 1.58e-12) on chr8p23.2 and RBFOX1 (p = 9.76e-11) on chr16p13.3. CSMD1 is an important regulator of complement activation and inflammation (29, 30) while RBFOX1 encodes for an mRNA-splicing factor linked to autism spectrum disorders (31). A previous study in Tanzanian population reported association of variants in RBFOX gene with SM (17).

Other important genes identified by gene-based GWASs include neural adhesion molecules including CNTN4 (p = 3.88e-9) on chr3p26.3-p26.2; PCSK5(p = 2.88e-11) on chr9q21.13; CDH13 (p = 4.19e-8) on chr16q23.3) and TMEM132 (p = 2.18e-8) on chr17q12 (Supplementary Data 5). These genes were reported to be linked to autism spectrum disorders and other neurodevelopmental conditions (32). Furthermore, protein kinases including FLT4 (p = 9.96e-8) on 5q35.3; and PTPRT (p = 4.92e-7) on chr20q12-q13 and PRKG1 ((p = 1.2e-6) on 10q11.2-q21.1 were among the genes with top scores (Supplementary Data 5). PTPRT is a tyrosine phosphatase receptor involved in STAT3 pathway and was recently reported to be associated with mild malaria susceptibility in Benin populations (33). PRKG1 is a cyclic guanosine monophosphate (GMP) dependent protein kinase which plays important roles in relaxation of vascular smooth muscle and inhibition of platelet aggregation (34). FLT4 acts as a cell-surface receptor for vascular endothelial growth factor C (VEGFC) and vascular endothelial growth factor D (VEGFD), and plays an essential role in the development of the vascular network (35). It has been shown that VEGF and its receptor-related molecules are expressed in the brain tissues and reported to play protective during CM (36).

Gene-based rare variant association

Because rare variants are known to play role in the variation of most complex traits, we applied optimal unified sequence kernel association test (SKAT-O), which combines burden and variance-component analyses (37) to the raw genotype GWAS dataset of Gambia, Kenya and Malawi populations (see Material and Methods). The SKAT-O analysis identified a total of six and nine nominally significant genes in Gambia and Malawi populations, respectively. These include nine long intergenic non-protein coding RNAs (LincRNAs), MIR4282, GLYR1, NDNF, EPB41L2, ATP8A1 and WASF3 (Supplementary Table 3). However, none of these genes were significant after correction for multiple testing.

Functional networks and subnetworks of severe malaria resistance candidate genes

To investigate the functional interaction between all the candidate malaria resistance candidate genes identified in this study, we implemented network analysis (see Materials and Methods). Our global network generated 351 functional interactions between 268 genes. Topology analysis identified ABO, HBB, HBD, HBE1, ATP2B4 as highly influential connector hub genes influencing at least two subnetworks/communities while TRIM21 and OR5F2 constituted independent communities. MED22 and OR551B6 constituted provincial hub genes (Fig 3).

Fig. 3.
Fig. 3.

Network generated from predominant severe malaria protective candidate genes, comprising of 351 interactions between 268 nodes. Topology analysis identified ABO, HBB, HBD, HBE1, ATP2B4 as highly influential connector hub genes influencing at least two subnetworks/communities while TRIM21 and OR5F2 constituted independent communities. MED22 and OR551B6 constituted provincial hub genes.

Molecular functions and pathways of candidate severe malaria resistance genes

To test whether the genes predicted by the three functional mapping strategies overlapped in functional gene sets and pathways, we conducted gene enrichment analysis implemented in FUMA (20) using MsigDBc5 (38) gensets as background (see Material and Methods). The gene enrichment analysis identified several shared biological functions linked to erythrocyte-related pathways including three gene ontology (GO) cellular components, eight GO molecular functions and fourteen GO biological processes (Table 2). The implicated cellular components include haptoglobin-haemoglobin complex (p = 7.6e-8), haemoglobin-complex(p = 7.63e-8) and cytosolicpart (p = 6.73e-3). The enriched molecular functions include haptoglobin binding (p = 4.87e-8), oxygen carrier activity(3.8e-7), oxygen binding (p = 4.87e-5) and other activities related to haemoglobin functions. The shared biological activities include oxygen transport (p = 4.22e-6), gas transport (p = 4.87e-6), hydrogen peroxide catabolism (p = 9.08e-5), protein hetero-oligomerization (p = 2.86e-3), protein complex-oligomerization (p = 4.23e-3), interferon gamma mediated signalling pathways (p = 3.09e-2) and blood coagulation (p = 3.09e-2).

View this table:
Table 2. Gene enrichment results of functionally annotated genes in malaria genomic risk loci identified by FUMA method

In addition to genes within severe malaria genomic risk loci, we performed functional analysis and pathway analysis for the genes identified by the gene-based GWAS using Database for Annotation, Visualization and Integrated Discovery (DAVID) method (39) and Pascal (22), respectively(see Material and Methods). The DAVID analysis yielded eight functional categories, the majority of which are linked to malaria pathogenesis (Table 3) including GPCR signalling, membrane/transmembrane proteins, Na+/K+ transporting ATPases, cell adhesions, haemoglobin related functions, calcium signalling and actin binding activities.

View this table:
Table 3: Functional categories of genes identified by gene-based GWAS analysis grouped using DAVID method

Similarly, Pascal analysis implicated eleven significant pathways the majority of which are linked to malaria pathogenesis in RBCs, vasculatures and brain (Fig 4A). These include G protein-coupled receptor signalling (p = 7.88e-15), haemostasis (p = 4.52e-10), neuronal system (p = 1.25 e-9), axon guidance (p = 5.93e-8), calcium signalling (p = 1.10e-7), chemical transmission across synapses (p = 1.75 e-7), immune system (p = 2.61e-6), signalling by Rho GTPase (p = 1.45 e-5) and tight junction (p = 3.57 e-5). Furthermore, differential expression of genes implicated by Pascal method showed significant enrichment in blood vessels (Fig 4B).

Fig. 4.
Fig. 4.

A) Pathway scores obtained from pascal analysis. Significant Pathways at Bonferroni corrected P-value ≤ 0.05 are coloured in red. B) Tissue specific gene expression and shared biological functions of genes identified by pascal in GTEx v8 30 general tissue types. Input genes were tested against each of the precomputed differentially expressed sets using the hypergeometric test. Significant enrichment at Bonferroni corrected P-value ≤ 0.05 are coloured in red.

Population genetic structure of malaria resistance candidate genes

We noted that the minor allele frequencies (MAF) of the SNPs residing in the identified genes are generally higher in the three malaria populations compared to 20 ethnic groups (Supplementary Fig 1 and 2). We further observed that the proportion of pathogenic SNPs in a total of eighteen genes is much higher in the three malaria endemic populations compared to other populations (Supplementary Data 6 and 7). These include TRIM family genes such as TRIM21, TRIM22, TRIM68, TRIM6-TRIM34 and TRIM34 in which the pathogenic SNP proportion ranges from 13.3–25%; olfactory receptors genes such as: OR51B4, OR51B6, OR51B2, OR56A1, OR51L1, OR52K2 and OR51E2 in which the pathogenic SNP proportion ranges from (27.3 –100%).

The principal component analysis based on the SNPs residing in the identified genes effectively clustered all the populations according their ancestry (Fig 5).

Fig.5.
Fig.5.

A) We clustered the merged malaria GWAS dataset containing only SNPs residing in the identified malaria resistance candidate genes (N = 10578 samples, 15,675 SNPs) using smartpca software. The three populations and their case/control status were indicated by different colours and symbols. B). We clustered the AGVP dataset containing only SNPs residing in the identified malaria resistance candidate genes (N = 4932 samples, 93,5549 SNPs) in to sub-regions/populations using smartpca software. The populations were indicated by different colours and symbols.

Discussions

In this study, we applied statistical functional analytic method to the largest ever severe malaria susceptibility GWAS dataset and identified the well-known malaria resistance loci and a number of novel genes that can guide future functional experiments. We noted that severe malaria resistance is attributed to multiple genes and pathways linked to malaria pathogenesis during blood stage life cycle of the parasite including merozoite invasion, parasite growth, cytoadherence, and signal transduction. The genes that were identified by our three mapping strategies might have equal importance; genes that were identified by positional mapping may act at protein level through structural changes while the genes identified by eQTL and chromatin interactions exert their influences through quantitative changes at gene expression levels (20).

The fact that the functionally mapped genes are clustered on chromosome 11p15 is consistent with our recent work in which we reported the disproportionate concentration of SNP-heritability on chromosome eleven. This might reinforce the need for targeting this chromosome in the future severe malaria susceptibility studies (11). We noted that in addition to the sickle trait gene (HBB), our mapping strategies identified other members of beta globin gene cluster that cause various forms of beta-thalassemia (HBE1, HBD, HBG and HBG2).

Our network analysis showed that all these genes constituted hub with which several other genes are connected; which reaffirm the importance of homeopathies in resistance against severe malaria. Beta-thalassemia and other hemoglobinopathies are thought to confer protection against severe malaria by suppressing the parasite growth and by mitigating associated pathogenic effects (40). The proposed protective mechanisms of hemoglobinopathies against severe malaria has been extensively reviewed elsewhere (40, 41). In addition to the beta globin gene cluster, the Tripartite motif (TRM) containing gene family (TRIM68 and TRIM21) identified in this locus are known to play critical role in down regulating Toll-like receptors(TLR)- and Rig-like receptors (RLR)-induced responses and protect from autoimmune and inflammations (42, 43). Mal-adapted inflammatory reactions is one of the hall mark pathogenic pathways in severe malaria (44, 45). The olfactory receptors super-family genes (CCKR, OR51F2 and OR51L) identified in this locus might involve in G protein-coupled receptors(GPCR) signalling activities which is important in blood stage life cycle of P. falciparum (46). However, it is also possible that these genes were detected because of their abundance and close proximity to with globin gene cluster(47). We also be noted that the genes in the TRM family and olfactory receptors super-family contain higher proportion of pathogenic SNPs in the three-malaria endemic population compared to the global populations. The majority of the well-known malaria protective genes have deleterious variants and were evolved under balancing selections [42].

Our eQTL mapping identified ADAMTS13 gene on chr9q34 outside the malaria genomic risk locus which would not have been identified by the conventional SNP mapping approach (20). ADAMTS13 is a zinc-containing metalloprotease enzyme that cleaves, von Willebrand factor vWF, a large protein derived from endothelial surface and megakaryocytes which plays a crucial role in basic haemostasis (48, 49). Following activation of endothelial cells, vWF is directly released in to plasma and basement membrane or is stored in Weibel–Palade bodies (WPBs) from where it is released by regulated secretion to promote adhesion of platelets at the sites of vascular injury and facilitate vascular healing (49). However, abnormal accumulations of vWF caused by deficiency of plasma ADAMTS13 trigger intravascular platelet aggregation and micro thrombosis leading to a vascular disease, Thrombotic Thrombocytopenic Purpura (TTP) (48). Indeed, recent works have linked the platelet-mediated clumping of infected erythrocytes in microvasculature during cerebral malaria with increased level of VWF in plasma caused by mutations in ADAMTS13 genes (50–52).

In the same genomic locus, our eQTL functional mapping identified surfeit gene cluster, metalloprotease genes linked to epithelial adhesions and blood coagulations. SURF4 gene has been implicated in epithelial cell adhesion trait (53), MED22 gene is linked to VWF factor/factor VIII level measurement (54) and SURF6 has been implicated in epithelial ovarian cancer (55). Our network analysis showed that MED22 forms a central hub to which the rest of surfeit gene cluster are connected. This may suggest that the greater importance of MED22 gene compared with the other members of the cluster. However, further comprehensive studies are needed to better understand the association of these genes with SM resistance. In the remaining genomic risk loci, the well-known genes including ATP2B4 (chr1q32), FREM3, GYPE and GYPB (chr4p31) were replicated and few additional genes were identified. The glycophorin gene cluster, GYPA and GYPB encode the MNS blood group system and are host-erythrocyte receptors for P. falciparum; suggesting that polymorphisms in these genes play protective role by interfering with the invasion processes [55]. ATP2B4 variants may impair the parasite lifecycle in erythrocyte by affecting intracellular Calcium homeostasis (18, 56).

Novel genes identified in the loci include BTG2 on chr1q32 and B3GALNT1 on chr3q26. BTG2 is a tumour suppressor gene known to be linked to RBC related traits including MCHC level, RBC distribution and reticulocyte count (57). B3GALNT1 encodes globoside blood group system which is determined by P antigen (58). Globoside/P antigen is the most abundant neutral glycolipid in the erythrocyte membrane and has been recognized as a cellular receptor for parvo-B19 virus (59). Individuals lacking this receptor are resistant to parvo-B19 virus and uro-pathogenic E.coli infections (59, 60). Further investigations are needed to establish the link between these genes and SM resistance.

We noted that the mapped genes share cellular components including haptoglobin binding, haemoglobin complex and cytosolic part and several overlapped molecular functions and biological processes linked with the blood stage life cycle of the parasite. P. falciparum spends most of its lifecycle within RBCs, where it undergoes multiple rounds of invasion, growth, replication and egress; causing the signs and symptoms of malaria (44, 61). The majority of the classical haemoglobin variants confer protection against severe malaria by restricting invasion process and intraerythrocytic growth of the parasite (40). Haptoglobin is an acute phase glycoprotein present in human plasma. It forms stable complexes with extracellular haemoglobin that is released from lysed RBCs and thereby curtail the haemoglobin-induced oxidative tissue damage (62).

P. falciparum ingest the host cell cytosol to obtain nutrients and space for growth in the RBCs (63). A recent study showed that the host cytosol uptake process is mediated by parasite’s protein called VPS45 (64). The fact that the identified candidate genes in this study were enriched in the cytosol part of the cellular component might suggest that these genes might arrest the nutrient uptake of the parasites and thereby confer protection against their pathogenic effects. In addition to haemoglobin related functions, some of the candidate genes were enriched in other pathways linked to malaria pathogenesis including blood coagulation related processes malaria (65, 66) and interferon gamma mediated signalling pathways (67, 68). This may suggest that the host genetic factors might interfere with parasite development and its pathogenic outcomes at multiple levels to confer protection the life-threatening form of malaria.

Our gene-based GWAS analysis replicated the well-known malaria resistance candidate genes in the genomic risk loci and identified several genes across the genome. Genes with top scores encode for different malaria relevant functions such as: regulation of inflammation (CSMD1), neural adhesion (CNTN4, PCSK5, CDH13, TMEM132), vascular epithelial development (FLT4) and protein kinases (PTPRT, PRKG1). Furthermore, functional analysis of the candidate genes yielded functional categories linked with the blood stage lifecycle of the parasite and associated pathologies. The top enriched functions include GPCR signalling, membrane/transmembrane proteins, [Na+/K+] transporting ATPases, Sodium leak and Potassium channel interacting proteins, cell adhesions molecules and Calcium/Calmodulin-dependent protein kinases (CDPKs). CDPKs have crucial functions in calcium signalling at various stages of the parasite’s life cycle and is proposed to be one of the potential drug targets against malaria (69). It has been shown that P. falciparum infection activates host signalling pathway involving protein kinase C (PKC) (70). Similarly, host GPCR signalling pathways have been shown to play vital roles in invasion, intraerythrocyte parasite development and egress processes (71, 72); suggesting the existence of substantial interactions between host membrane/transmembrane signalling and parasite signalling elements which might mediate the disease severity. Further studies are needed to decouple the host-parasite interface of signal transduction and explore the potential target for new therapeutics. Sodium leak and Potassium channel interacting proteins, [Na+/K+] transporting ATPases play critical role in maintaining electrochemical equilibrium in normal erythrocytes. However, upon invasion by trophoblast stage of the parasite, the ion pump-leak balance is perturbed; with increased leak rate and decreased pump rate resulting in a remarkable increase in [Na+] and decrease in [K+] in the erythrocyte cytosol (73, 74). This results in formation of a new permeability pathway (NPP) in the erythrocyte membrane which allow the transport of nutrients and waste products necessary for the parasite. The composition and physiological role of NPP has been reviewed elsewhere (75, 76). Studies have shown that both parasites driven proteins encoded by clag3.1 and clag3.2 (77, 78) and host benzodiazepine receptor mediate the formation of NPP (79, 80). Our result may suggest the existence of multiple host genes that are involved in mediating this process. Given that TPP can be a potential target for new therapeutics, further studies are needed to investigate the role of host and parasites genetics in mediating the channel and its pathophysiology.

In addition to the well-known pathways such as: haemostasis and immune system that play role in malaria resistance (13), our analysis identified novel pathways including cell adhesion molecules, Rho GTPase activities, tight junction, neuronal system and axon guidance. One of the key virulence factors of P. falciparum is its capacity to modify iRBCs to adhere to the endothelium of the vasculature and, thereby, sequester in capillaries and postcapillary venules in vital organs leading to severe disease manifestations (61). Adhesion phenotype is mediated by expression of P. falciparum erythrocyte membrane protein 1 (PfEMP1) on the iRBCs (81, 82). The binding of iRBCs with endothelium involve various adhesion molecules including CD36, ICAM-1, E-selectin and chondroitin sulfate A (CSA) that are variably expressed in different organs (83–85). The neural adhesion molecules identified in the current study might involve in receptor activities and their polymorphisms might play protective roles against SM. Furthermore, adhesion events have been shown to activate Rho kinase signalling pathway which is strongly implicated in various vascular diseases (86). The genes that are enriched in these pathways might provide protection against severe malaria by weakening the cytoadherence interactions and associated pathologies. Other genes that are enriched in neuronal system, axon guidance and tight junction might be linked with intra cerebral pathogenesis of SM (87). Furthermore, the candidate malaria resistance genes identified by gene-based GWAS were differential expressed in blood vessels; suggesting that the majority of the identified genes are likely counteract P. falciparum induced endothelial disfunctions in microvasculature and capillaries (44).

In conclusion, our functional mapping analysis identified 57 genes located in the known malaria genomic loci while our gene-based GWAS analysis identified additional 125 genes across the genome which can potentially guide future experimental studies. The identified genes were significantly enriched in malaria pathogenic pathways including multiple overlapping pathways in erythrocyte-related functions, blood coagulations, ion channels, adhesion molecules, membrane signaling elements and neuronal systems. Overall, our results suggest that severe malaria resistance trait is attributed to multiple genes that are enriched in overlapping pathways linked to severe malaria pathogenesis; highlighting, the possibility of harnessing new malaria therapeutics that can simultaneously target multiple malaria protective host molecular pathways. Further experimental studies are needed to validate the findings in the current study.

Materials and Methods

Description of the study datasets

We accessed a previous severe malaria GWAS datasets (16) (N = ∼11,000) of three African populations including Kenya, Gambia and Malawi from European Phenome Genome Archive (EGA) following the standard data access protocols outlined in (88, 89). Children with severe malaria cases were recruited on admission to hospital using definitions as per WHO guidelines for cerebral malaria (Blantyre coma score < 3 in children or Glasgow coma score < 11 in adults), severe malarial anaemia (haemoglobin < 5 g/100 mL or haematocrit < 15%) and other malaria-related symptoms (90). Control samples were obtained from representative of the ethnic groups of the cases or in some study sites from the local population (89). The samples were genotyped on Illumina Omni 2.5Marray and QC filtered as described in (14). In addition to the genotype dataset, we obtained a set of severe malaria susceptibility GWAS summary statistics (N = 17,000) meta-analysed across eleven population in Africa, Oceania and Asia from (18). The dataset contained information on GWASs of individual study populations and their meta-analysis. We additionally accessed a merged data set from 1000 Genomes Project and African Genome Variation Project(AGVP)(91) of which 20 world-wide ethnic groups (Supplementary Table 4) have been grouped following ethno-linguistic information (92).

Functional mapping and annotations

We used the meta-analyzed malaria GWAS summary statistics (N = 17,000 samples, 17million SNPs) across eleven populations(18) for functional mapping and annotations. We implemented FUMA(20), a pipeline that determines genomic risk loci and prioritize potential causal genes by incorporating information from multiple sources including GTEx (93), ENCODE (25), Roadmap Epigenomics Project (26) and chromatin interaction information (27). Briefly, a pre-calculated LD structure based on 1000 Genome version 3 of the African population was used to determine the risk loci and independent significant SNPS from the GWAS summary statistics data. Independent significant SNP was defined as a genome-wide significant SNP (P-value < 5e-8) within LD threshold of r2 > 0.6. Other nominally significant SNPs (p< 0.05) that are in LD (r2 < 0.6) with independent significant SNPs were designated as candidate SNPs and included for annotation analysis. From identified independent significant SNPs, lead SNPs were selected at LD threshold of r2 > 0.1. SNPs in close proximity (< 250 k) were considered as a single locus and thus, each genomic locus can contain multiple independent significant SNPs and lead SNPs.

We then implemented three gene mapping strategies including positional mapping, expression Quantitative Trait Locus (eQTL) mapping, and chromatin interaction implemented in FUMA(20). Positional mapping was performed by ANNOVAR tool (94) using Ensembl (build 85; http://www.ensembl.org/) dataset. A maximum distance of 10kb window size upstream and downstream was used to map SNPs to genes. SNPs filtering was carried out based on CADD score(95), RegulomeDB score (96) and 15-core chromatin state (97).

eQTL mapping was performed for genes within 1 Mb of the most significant variant using datasets that contain eQTL information related to severe malaria such as brain and blood. These include:PsychENCODE(98), GTExv8 (93), BRAINEAC (99), DICE (100), eQTLGen (101) (and Blood eQTLbrowser (102) and scRNA_eQTLs(103). Chromatin interaction mapping was performed using dataset including Hi-C data of 21 tissues/cell types obtained from GSE87112. (104), Hi-C loops from Giusti-Rodriguez et al. 2019 (105) which contains pre-processed enhancer-promoter and promoter-promoter interactions based on Hi-C data for adult and foetal human brain samples(105), Hi-C based data from PsychENCODE (98) which is composed of Enhancer-Promoter links based on Hi-C and Promoter anchored Hi-C loops and Enhancer-Promoter correlations from FANTOM5 (106). We restricted our analysis to tissues related to severe malaria pathogenesis. Genes prioritized by any of these three strategies were considered as potential causal genes. To gain insights in to the biological functions of prioritized genes, we performed gene enrichment analysis using an hypergeometric test in which gene-sets obtained from MsigDB (38) and WikiPathways (107) were used as background genes. We further tested differential gene expression values on 54 tissues obtained from the GTEx (93) as indicted FUMA (20).

Gene-based genome-wide association analysis

Considering the polygenic nature of severe malaria susceptibility trait (11), we applied Pascal (22), a gene-based GWAS analysis that can aggregate all SNPs within a gene and thus, capture modest effects. Briefly, Pascal sum of chi-squared statistics (SOCS) analysis was applied to nominally significant GWAS SNPs (p-value < 0.05) and to compute the corresponding gene scores (p-values) in 50kb upstream and downstream window. LD information for estimation of correlation structure was obtained from African dataset in 1000G phase 3 (108). We further categorized the prioritized genes in to different functional groups using DAVID tools (39). Significant genes were subjected to differential gene expression analysis implemented in FUMA software using 54 tissues obtained from the GTEx (93). Pathway scores were computed by combining the scores of genes that belong to the same gene-set. The analysis doesn’t require a gene score threshold and incorporates weakly associated genes for pathway enrichment. Gene-fusion parameter was set to 1Mb so that all pathway-member genes within 1Mb apart were fused together. Genes in HLA-region and those containing more than 3000 SNPs were removed as outlined in Pascal documentations (22).

Gene burden and rare-variants association tests

Given that the GWAS assumption is based on common variant common disease hypothesis, GWAS approach always miss potential association signal from rare variants. To examine the contribution of rare variants, we applied optimal unified sequence kernel association test (SKATO), which combines burden and variance-component analyses (37) to the GWAS dataset of Gambia, Kenya and Malawi populations. Briefly, we aligned the VCF files including Gambia (N = 4920 samples, 1.6 million SNPs), Malawi (N = 2560 samples, 1.6 million SNPs) and Kenya (N = 3143 samples, 1.6 million SNPs) to GWAS dataset to 1000 Genome v-3 reference haplotypes using Genotype Harmonizer (109) and removed SNPs with position and strand mismatches and phased using SHAPEITv2 (110). We performed imputation using impute 2 (111) and obtained ∼ 20 million from each population. After removal SNPs with low genotype rate and imputation accuracy, we retained ∼15,000 SNPs in each population. We then applied SKAT-O test to the quality filtered data following the procedure outlined in SKAT package (37).

Network analysis

We performed a network analysis to investigate the functional interaction between malaria resistance candidate genes. Briefly, we obtained functional interaction network from of the identified candidate malaria resistance genes using Multiple Association Network Integration Algorithm (geneMANIA) tool (112). Using this information, we computed network parameters including degree, betweenness and closeness centrality metrics to evaluate the topology of nodes(genes) and edges(interactions) in the network using networkX (113) and R igraph packages (114).

Closeness measures the average distance from the node to all other nodes in the network, indicating which nodes represent a greater “risk” (maximally close with lowest sum of edge weights) for eliciting other nodes. Betweenness measures the number of times that a node lies on the shortest path between two other nodes, indicating which nodes serve as a “hub” between other nodes (114). The degree of a node is described as the number of direct connections it has with other nodes within the network. Low degree nodes usually connect to nodes within their local community whereas high degree nodes usually extend to the neighbouring community (114). Using the centrality scores, we quantified node centrality to identify hub genes by investigating the contribution of the edges and the weight of the edges towards node centrality. The hubs genes make strong contributions to the subnetwork and/or global network integrity. Connector hubs and provincial hubs refers to nodes that link other nodes across different communities and local communities, respectively.

Population genetic structure of malaria-specific resistance candidate genes

We performed the population genetic structure of the identified genes in malaria endemic populations (Kenya, Gambia and Malawi) and global populations of 20 ethnic groups obtained from African Genome Variation Project (AGVP) (91). We mapped a total of 14,106,476 SNPs to the identified candidate genes using dbSNP database. We merged the quality filtered GWAS datasets of the three malaria endemic populations using PLINK software (115) and retained dataset that contains the SNPs that are mapped to the identified genes (N = 10578 samples, 15,675 SNPs). We performed basic quality control, removed structural variants and ambiguous SNPs using PLINK software (115) as described elsewhere (116). We retained AGVP dataset containing only the SNPs that are mapped to the identified candidate genes (N = 4932 samples, 93,5549 SNPs). We then partitioned these datasets in to a total 23 different Ethnic groups (20 from AGVP and 3 from malaria endemic populations) based on population or country labels information. We clustered the merged malaria GWAS dataset and the AGVP dataset containing only SNPs residing in the identified genes in to sub-regions/populations using smartpca software (117). For each ethnic group, we computed various population genetics analysis including minor allele frequency (MAF) at various bins and gene-specific in SNPs MAF by aggregating MAF of all associated SNPs within gene from dbSNPs. We finally computed proportion of pathogenic SNPs within the candidate genes using ANNOVAR software (94) by computing the number of SNPs reported to be pathogenic over total numbers associated SNPs within gene from dbSNPs.

Data Availability

The GWAS summary statistics used in this study can be found at https://www.malariagen.net/sppl25/

Funding

DD, FA, PK, NK, HG and LG are funded by The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan Africa (DELGEME) program (grant #PD00217ML). EC is funded by NIH projects

Declaration of interest

The authors declare that they have no competing interests.

Authors contributions

DD designed, performed the data analysis and drafted the manuscript, FA, PK, NK, WT, HG and LG contributed in data analysis and revision of the manuscript, EC supervised the work

Supplementary Figures and Tables

Supplementary Fig 1.
Supplementary Fig 1.

Chromatin interactions and eQTLs of severe malaria resistance candidate genes on chr 11 risk locus. The most outer layer is the Manhattan plot displaying SNPs with P-value < 0.05. Candidate SNPs are coloured based on the highest r2 to one of the independent significant loci (red: r2 > 0.8, orange: r2 > 0.6). Other SNPs are coloured in grey. The outer circle is the chromosome coordinate and genomic risk loci are highlighted in blue. Genes mapped by either Hi-C or eQTLs are shown on the inner circle. Genes identified by chromatin interaction and eQTLs are coloured orange and green respectively while genes mapped by both are coloured red.

Supplementary Fig 2.
Supplementary Fig 2.

Chromatin interactions and eQTLs of severe malaria resistance candidate genes on chr 9 risk locus. The most outer layer is the Manhattan plot displaying SNPs with P-value < 0.05. Candidate SNPs are coloured based on the highest r2 to one of the independent significant loci (red: r2 > 0.8, orange: r2 > 0.6). Other SNPs are coloured in grey. The outer circle is the chromosome coordinate and genomic risk loci are highlighted in blue. Genes mapped by either Hi-C or eQTLs are shown on the inner circle. Genes identified by chromatin interaction and eQTLs are coloured orange and green respectively while genes mapped by both are coloured red

Supplementary Fig 3.
Supplementary Fig 3.

Minor allele frequency bins of SNPs mapped to severe malaria resistance candidate genes in three malaria endemic populations (Gambia, Malawi, Kenya) and global populations of 20 ethnic groups. Y-axis represent allele frequency, X-axis represent different MAF bins. Populations were represented by different colors and symbols

Supplementary Fig 4.
Supplementary Fig 4.

Gene specific MAF of SNPs mapped to severe malaria resistance candidate genes in three malaria endemic populations (Gambia, Malawi, Kenya) and global populations of 20 ethnic groups. Y-axis represent gene specific allele frequency, X-axis represent genes. Populations were represented by different colors and symbols

View this table:
Supplementary Table 1. Positional enrichment of genes identified by FUMA method using MsigDB genes as background
View this table:
Supplementary Table 2.

Candidate malaria resistance genes identified by both functional mapping and gene-based GWAS analysis

View this table:
Supplementary Table 3.

Nominally significant genes obtained from burden and rare variant analysis using SKAT package

Acknowledgements

This work was supported through the DELTAS Africa Initiative [grant 107740/Z/15/Z]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant 107740/Z/15/Z] and the UK government. The authors would also like to thank the National Research Foundation of South Africa for funding (NRF) [grant # RA171111285157/119056] and The Centre for High-Performance Computing (CHPC, http://www.chpc.ac.za) for computing resources This study makes use of data generated by MalariaGEN. A full list of the investigators who contributed to the generation of the data is available from http://www.malariagen.net. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government.

References

  1. 1.↵
    World Health Organization(WHO). World malaria report. 2019
  2. 2.↵
    World Health Organization(WHO). World malaria report. 2018
  3. 3.↵
    Egan A, Keusch GT, Breman JG. The intolerable burden of malaria: a new look at the numbers.200. Am J Trop Med Hyg;64
  4. 4.↵
    World Health Organization(WHO). Severe Malaria. 2014;19: 7–131. doi:10.1111/tmi.12313
    OpenUrlCrossRef
  5. 5.↵
    Dhiman S. Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead. IDP; 2019; 1–19.
  6. 6.↵
    Newby G, Bennett A, Larson E, Cotter C, Shretta R, Phillips AA, et al. The path to eradication: a progress report on the malaria-eliminating countries. The Lancet. 2016; 1775–1784.
  7. 7.↵
    Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature. 2002;415: 673–679. doi:10.1038/415673a
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Cowman AF, Crabb BS. Invasion of Red Blood Cells by Malaria Parasites. Cell. 2006; 755–766. doi:10.1016/j.cell.2006.02.006
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Kevin M, Dayo F, Catherine W, Isiah M, Maria W, Victoria M, et al. Indicators of life-threatening malaria in african children N Engl J Med. 1995;332: 1399–1404.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Damena D, Denis A, Golassa L, Chimusa ER. Genome-wide association studies of severe P. falciparum malaria susceptibility: progress, pitfalls and prospects. BMC Med.Genom.; 2019; 1–14.
  11. 11.↵
    Damena D, Chimusa ER. Genome-wide heritability analysis of severe malaria resistance reveals evidence of polygenic inheritance. HMG. 2020;29: 168–176. doi:10.1093/hmg/ddz258
    OpenUrlCrossRef
  12. 12.↵
    Teo Y, Small KS, Kwiatkowski DP. Methodological challenges of genome-wide association analysis in Africa. Nat Rev Genet. 2013;11: 149–160.doi:10.1038/nrg2731.
    OpenUrlCrossRef
  13. 13.↵
    Kwiatkowski DP. How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria. Am J Hum Genet. 2005;77: 171–192. doi:10.1086/432519
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Jallow M, Teo YY, Small KS, Rockett KA, Clark TG, Kivinen K, et al. Genmone-wide and fine-resolution association analysis of malria in West Africa. Nat Genet. 2010;41: 657–665. doi:10.1038/ng.388.Genome-wide
    OpenUrlCrossRef
  15. 15.
    Timmann C, Thye T, Vens M, Evans J, May J, Ehmen C, et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature. 2012;489. doi:10.1038/nature11334
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Band G, Rockett KA, Spencer CCA, Kwiatkowski DP, Si Le Q, Clarke GM, et al. A novel locus of resistance to severe malaria in a region of ancient balancing selection. Nature. 2015;526: 253–257. doi:10.1038/nature15390
    OpenUrlCrossRefPubMed
  17. 17.↵
    Ravenhall M, Campino S, Sepu N, Nadjm B, Mtove G, Wangai H, et al. Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania. PloS Genet. 2018; 1–15.
  18. 18.↵
    Gavin B, Quang S Le, Geraldine MC, Katja K, Christina H, Anna EJ, et al. Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania. Nat Commun. 2019;10: 5732. doi:doi.org/10.1038/s41467-019-13480-z
    OpenUrlCrossRef
  19. 19.↵
    Chimusa ER, Mbiyavanga M, Mazandu GK, Mulder NJ. AncGWAS: A post genome-wide association study method for interaction, pathway and ancestry analysis in homogeneous and admixed populations. Bioinformatics. 2015;32: 549–556. doi:10.1093/bioinformatics/btv619
    OpenUrlCrossRefPubMed
  20. 20.↵
    Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun; 2019: 1–10. doi:10.1038/s41467-017-01261-5
    OpenUrlCrossRefPubMed
  21. 21.
    Leeuw CA De, Mooij JM, Heskes T, Posthuma D. MAGMA: Generalized Gene-Set Analysis of GWAS Data. PLoS Comput. Biol; 2015; 1–19. doi:10.1371/journal.pcbi.1004219
    OpenUrlCrossRefPubMed
  22. 22.↵
    Lamparter D, Marbach D, Rueedi R, Kutalik Z. Fast and Rigorous Computation of Gene and Pathway Scores from SNP-Based Summary Statistics. PloS Comput Biol. 2016; 1–20. doi:10.1371/journal.pcbi.1004714
    OpenUrlCrossRefPubMed
  23. 23.↵
    Yoon S, Nguyen HCT, Yoo YJ, Kim J, Baik B, Kim S, et al. Efficient pathway enrichment and network analysis of GWAS summary data using GSA-SNP2. Nucliec acids Res. 2018;46. doi:10.1093/nar/gky175
    OpenUrlCrossRef
  24. 24.↵
    The GTex Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 2015;348: 648–661.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature. 2015;48:317–330
    OpenUrl
  27. 27.↵
    Schmitt, A. D. et al. A compendium of chromatin contact maps reveals spatially active regions in the human genome. Cell Rep. 2016; 17, 2042–2059
    OpenUrlCrossRefPubMed
  28. 28.↵
    Dudbridge F. Polygenic Epidemiology. Genet Epidemiol. 2016;40: 268–272. doi:10.1002/gepi.21966
    OpenUrlCrossRefPubMed
  29. 29.↵
    Sun PC, Uppaluri R, Schmidt AP, Pashia ME, Quant EC, Sunwoo JB, et al. Transcript Map of the 8p23 Putative Tumor Suppressor. Genomics; 2001;75: 17–25. doi:10.1006/geno.2001.6587
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    Lee AS, Rusch J, Lima AC, Usmani A, Huang N, Lepamets M, et al. Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility. Nat Commun. 2019; 10:1–16. doi:10.1038/s41467-019-12522-w
    OpenUrlCrossRefPubMed
  31. 31.↵
    Hamada N, Ito H, Nishijo T, Iwamoto I, Morishita R. Essential role of the nuclear isoform of RBFOX1, a candidate gene for autism spectrum disorders, in the brain development. Sci Rep. 2016; 1–19. doi:10.1038/srep30805
    OpenUrlCrossRef
  32. 32.↵
    Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, et al. Disruption of Contactin 4 (CNTN4) Results in Developmental Delay and Other Features of 3p Deletion Syndrome. Am. J. Hum. Genet. 2004;74: 1286–1293.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    Milet J, Boland A, Luisi P, Sabbagh A, Sadissou I, Sonon P, et al. First genome-wide association study of non-severe malaria in two birth cohorts in Benin. Hum Genet. 2019; 138:1341–1357
    OpenUrlCrossRef
  34. 34.↵
    Mro’zek K, Tanner M, Heinonen K, Bloomfield C. Molecular Cytogenetic Characterization of the KG-1 and KG-1a Acute Myeloid Leukemia Cell Lines by Use of Spectral Karyotyping and Fluorescence In Situ Hybridization. Gen, Chrom & Canc 2003;38:252: 249–252. doi:10.1002/gcc.10274
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, et al. FLT4) a Novel Class III Receptor Tyrosine Kinase in Chromosome. Canc Res. 1992; 746–748.
  36. 36.↵
    Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. PNAS. 2008;105: 17097–17102.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Ionita-laza I, Lee S, Makarov V, Buxbaum JD, Lin X. Sequence Kernel Association Tests for the Combined Effect of Rare and Common Variants. Am J Hum Genet. The American Society of Human Genetics; 2013;92: 841–853. doi:10.1016/j.ajhg.2013.04.015
    OpenUrlCrossRefPubMed
  38. 38.↵
    Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3. 0.Bionformatics. 2011;27: 1739–1740. doi:10.1093/bioinformatics/btr260
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    Jiao X, Sherman BT, Huang DW, Stephens R, Baseler MW, Lane HC, et al. DAVID-WS: a stateful web service to facilitate gene / protein list analysis. Bioinformatics. 2012;28: 1805–1806. doi:10.1093/bioinformatics/bts251
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Taylor SM, Cerami C, Fairhurst RM. Hemoglobinopathies: Slicing the Gordian Knot of Plasmodium falciparum Malaria Pathogenesis. PLoS Pathog. 2013;9. doi:10.1371/journal.ppat.1003327
    OpenUrlCrossRefPubMed
  41. 41.↵
    Hedrick P. Population genetics of malaria resistance in humans. Heredity. 2011;10716: 283–304. doi:10.1038/hdy.2011.16
    OpenUrlCrossRef
  42. 42.↵
    Wynne C, Lazzari E, Smith S, McCarthy EM, Nı’ Gabhann J, et al. TRIM68 Negatively Regulates IFN- b Production by Degrading TRK Fused Gene, a Novel Driver of IFN- b Downstream of Anti-Viral Detection Systems. PloS ONE 2014;9. doi:10.1371/journal.pone.0101503
    OpenUrlCrossRef
  43. 43.↵
    Foss S, Bottermann M, Jonsson A, Sandlie I, James LC, Andersen JT. TRIM21 — From Intracellular Immunity to Therapy. Frontiers Immun. 2019;10: 1–14. doi:10.3389/fimmu.2019.02049
    OpenUrlCrossRef
  44. 44.↵
    Moxon A. Christopher, Matthew PG, McGuinness D, Danny AM, Matthias M. New Insights into Malaria Pathogenesis. Ann Rev. 2020;15:313–343
    OpenUrl
  45. 45.↵
    Milner DA. Malaria Pathogenesis. Cold Spring Harb Perspect Med. 2018; 1–11.
  46. 46.↵
    Mbengue A, Yam XY, Braun-breton C. Human erythrocyte remodelling during Plasmodium falciparum malaria parasite growth and egress. BJH. 2012; 171–179. doi:10.1111/j.1365-2141.2012.09044.x
    OpenUrlCrossRefPubMed
  47. 47.↵
    Alonso S, Lo S, Izagirre N. Overdominance in the Human Genome and Olfactory Receptor Activity. Mol. Biol. Evol. 2008;25:997–1001. doi:10.1093/molbev/msn049
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    Zheng X. Long. ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura. Annu Rev Med. 2015; 66:211–225. doi:10.1146/annurev-med-061813-013241.
    OpenUrlCrossRefPubMed
  49. 49.↵
    Sporn LA, Marder VJ, Wagner DD, Stel H V, Mourik JA Van. Differing Polarity of the Constitutive and Regulated Secretory Pathways for von Willebrand Factor in Endothelial Cells. J.Cell.Biol. 1989;108: 1283–1289.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    Adams Y, Kuhnrae P, Higgins MK, Ghumra A, Rowe JA. Rosetting Plasmodium falciparuminfected erythrocytes bind to human brain microvascular endothelial cells in vitro, demonstrating a dual adhesion phenotype mediated by distinct P. falciparum erythrocyte membrane protein 1 domains. Infect Immun. 2014;82: 949–959. doi:10.1128/IAI.01233-13
    OpenUrlAbstract/FREE Full Text
  51. 51.
    Hollestelle MJ, Mantey EA, Chakravorty SJ, Craig A, Akoto AO, Donnell JO, et al. von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. BJH. 2006; 562–569. doi:10.1111/j.1365-2141.2006.06067.x
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    Kraisin S, Naka I, Patarapotikul J, Nantakomol D, Nuchnoi P. Association of ADAMTS13 polymorphism with cerebral malaria. Mal.J. 2011; 1–8.
  53. 53.↵
    Ahsan M, Ek WE, Rask-andersen M, Karlsson T, Lind-thomsen A, Enroth S, et al. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases. PloS Genet. 2017; 13:1–24.
    OpenUrlCrossRef
  54. 54.↵
    Sabater-Lleal M, Jennifer EH, Paul S de V, Jonathan M. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels. Circulations. 2019; 139:620–635. doi:10.1161/CIRCULATIONAHA.118.034532
    OpenUrlCrossRef
  55. 55.↵
    Chen K, Ma H, Li L, Zang R, Wang C, Song F, et al. Corrigendum: Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women. Nat Commun. 2014;5682: 6828. doi:10.1038/ncomms6828
    OpenUrlCrossRef
  56. 56.↵
    Tiffert T, Lew VL, Ginsburg H, Krugliak M, Croisille L, Mohandas N. The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum. Blood. 2005;105: 4853–4860. doi:10.1182/blood-2004-12-4948
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    Astle WJ, Elding H, Jiang T, Ouwehand WH, Butterworth AS, Soranzo N, et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease Resource. Cell. 2017; 1415–1429. doi:10.1016/j.cell.2016.10.042
    OpenUrlCrossRefPubMed
  58. 58.↵
    Hellberg Å, Poole J, Olsson ML. Molecular Basis of the Globoside-deficient P k Blood Group. J.Biol.Chem. 2002;277: 29455–29459. doi:10.1074/jbc.M203047200
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    Kevin EB, Jonathan RH, Giorgio G, Stancie MA, Elton DL, Peggy M, et al. Resistance to Parvovirus B19 infection due to Lack of virus receptor(Erythrocyte Antigen). N Engl J Med. 1994;330: 1192–6.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    Lund B, Lindberg FP, Baga M, Normark S. Globoside-Specific Adhesins of Uropathogenic Escherichia coli Are Encoded by Similar Trans-Complementable Gene Clusters. J.Bacteriol. 1985;162: 1293–1301.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    Rowe JA, Claessens A, Corrigan RA, Arman M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med. 2009;11: e16. doi:10.1017/S1462399409001082
    OpenUrlCrossRefPubMed
  62. 62.↵
    Kristiansen M, Graversen JH, Jacobsen C, Hoffman È, Law SKA, Sonne O, et al. Identintification of the haemoglobin scavenger receptor. Nature. 2001;409: 1999–2002.
    OpenUrl
  63. 63.↵
    Francis SE, Sullivan DJ, Goldberg DE. hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 1997; 97–123.
  64. 64.↵
    Jonscher E, Flemming S, Schmitt M, Spielmann T, Jonscher E, Flemming S, et al. PfVPS45 Is Required for Host Cell Cytosol Uptake by Malaria Blood Stage Parasites. Cell Host Microb. 2019; 166–173. doi:10.1016/j.chom.2018.11.010
    OpenUrlCrossRef
  65. 65.↵
    Francischetti IVOMB, Seydel KB, Monteiro RQ. Blood Coagulation, Inflammation, and Malaria. Microcirculation. 2008; 81–107. doi:10.1080/10739680701451516
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    Sullivan JMO, Preston RJS, Regan NO, Donnell JSO. Emerging roles for hemostatic dysfunction in malaria pathogenesis. Blood. 2016;127: 2281–2289. doi:10.1182/blood-2015-11-636464.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    Hunt NH, Ball HJ, Hansen AM, Khaw LT, Guo J, Bakmiwewa S, et al. Cerebral malaria: gamma-interferon redux. Frontiers Cell Infec. Microbiol. 2014;4: 1–12. doi:10.3389/fcimb.2014.00113
    OpenUrlCrossRef
  68. 68.↵
    Tosevski V, Forman R, Muller W, Couper N. crossm Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments. Infect Immun. 2017;85: 1–13.
    OpenUrlCrossRef
  69. 69.↵
    Ghartey-kwansah G, Yin Q, Li Z, Gumpper K, Sun Y, Yang R, et al. Calcium-dependent Protein Kinases in Malaria Parasite Development and Infection. Cell Transplant. 2020; 1–12. doi:10.1177/0963689719884888
    OpenUrlCrossRef
  70. 70.↵
    Sicard A, Semblat J, Doerig C, Hamelin R, Moniatte M, Dorin-semblat D, et al. Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes. Cell Microbiol. 2011;13: 836–845. doi:10.1111/j.1462-5822.2011.01582.x
    OpenUrlCrossRefPubMed
  71. 71.↵
    Brochet M, Billker O. Calcium signalling in malaria parasites. Cell.Microbiol. 2016; 12. doi:10.1111/mmi.13324
    OpenUrlCrossRefPubMed
  72. 72.↵
    Millholland MG, Mishra S, Dupont CD, Love MS, Patel B, Shilling D, et al. Article A Host GPCR Signaling Network Required for the Cytolysis of Infected Cells Facilitates Release of Apicomplexan Parasites. Cell Host Microb. 2013; 13:15–28.
    OpenUrl
  73. 73.↵
    Pillai AD, Addo R, Sharma P, Nguitragool W, Srinivasan P, Desai SA. Malaria parasites tolerate a broad range of ionic environments and do not require host cation remodelling. Mol Microbiol. 2013;88: 20–34. doi:10.1111/mmi.12159
    OpenUrlCrossRefPubMed
  74. 74.↵
    Desai SA. Why do malaria parasites increase host erythrocyte permeability? Cell. 2014;30: 151–159.
    OpenUrl
  75. 75.↵
    Kiaran K. Ion Regulation in the Malaria Parasite. Biochem. J. 2014:457, 1–18
    OpenUrlAbstract/FREE Full Text
  76. 76.↵
    Kirk K, Lehane AM. Membrane transport in the malaria parasite and its host erythrocyte. Biochem. J. 2014;18: 1–18. doi:10.1042/BJ20131007
    OpenUrlCrossRef
  77. 77.↵
    Nguitragool W, Bokhari AAB, Pillai AD, Rayavara K, Sharma P, Turpin B, et al. Malaria Parasite clag3 Genes Determine Channel-Mediated Nutrient Uptake by Infected Red Blood Cells. Cell. 2011;145: 665–677. doi:10.1016/j.cell.2011.05.002
    OpenUrlCrossRefPubMedWeb of Science
  78. 78.↵
    Ekland EH, Akabas MH, Fidock DA. Previews Taking Charge: Feeding Malaria via Anion Channels. Cell. 2011;145: 645–647. doi:10.1016/j.cell.2011.05.012
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.↵
    Bouyer G, Egée S, Thomas SL. Three types of spontaneously active anionic channels in malaria-infected. BCMD. 2006;36: 248–254. doi:10.1016/j.bcmd.2006.01.005
    OpenUrlCrossRefPubMedWeb of Science
  80. 80.↵
    Bouyer G, Cueff A, Gallagher PG, Thomas SLY. Erythrocyte peripheral type benzodiazepine receptor / voltage-dependent anion channels are upregulated by Plasmodium falciparum. Blood. 2011;118: 2305–2312. doi:10.1182/blood-2011-01-329300.
    OpenUrlAbstract/FREE Full Text
  81. 81.↵
    Heatwoie VM, Wertheimer SP, Peterson DS, Ravetch JA, Weilems TE. The Large Diverse Gene Family w Encodes Proteins Involved in Cytoadherence and Antigenic Variation of Plasmodium falciparum-Infected Erythrocytes. Cell. 1995;82: 89–100.
    OpenUrlCrossRefPubMedWeb of Science
  82. 82.↵
    Smith JD, Craig AG, Roberts DJ, Hudson-taylor DE, Peterson DS, Pinches R, et al. Switches in Expression of Plasmodium falciparum VW Genes Correlate with Changes in Antigenic and Cytoadherent Phenotypes of Infected Erythrocytes. Cell. 1995;82: 101–110.
    OpenUrlCrossRefPubMedWeb of Science
  83. 83.↵
    Raventos-suarez C, Kaul DK, Macalusot F, Nagel RL. Membrane knobs are required for the microcirculatory obstruction induced by Plasmodium falciparum-infected erythrocytes. Proc. Nadl. Acad. Sci. 1985;82: 3829–3833.
    OpenUrl
  84. 84.
    Rowe JA, Moulds JM, Newbold CI, Miller LH. mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Proc. Nadl. Acad. Sci. 1997;388: 292–295.
    OpenUrl
  85. 85.↵
    Fried M, Duffy PE. Adherence of Plasmodium falciparum to Chondroit i n Sulfate A in the Human Platen ta. Science. 1996;272: 4–6.
    OpenUrl
  86. 86.↵
    Taoufiq Z, Gay F, Balvanyos J, Ciceron L, Tefit M, Lechat P, et al. Rho Kinase Inhibition in Severe Malaria: Thwarting Parasite-Induced Collateral Damage to Endothelia. JID. 2008;197. doi:10.1086/528988
    OpenUrlCrossRefPubMed
  87. 87.↵
    Nishanth G, Schlüter D. Blood –Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention. Trends Parasitol. 2019;35: 516–528. doi:10.1016/j.pt.2019.04.010
    OpenUrlCrossRef
  88. 88.↵
    Parker M, Bull SJ, Vries J De, Agbenyega T, Doumbo OK, Dominic P. Ethical Data Release in Genome-Wide Association Studies in Developing Countries. PloS Med. 2009;6: 4–7. doi:10.1371/journal.pmed.1000143
    OpenUrlCrossRef
  89. 89.↵
    Achidi EA, Agbenyega T, Allen S, Amodu O, Bojang K, Conway D, et al. A global network for investigating the genomic epidemiology of malaria. Nature. 2008;456: 732–737. doi:10.1038/nature07632
    OpenUrlCrossRefPubMedWeb of Science
  90. 90.↵
    Trampuz A, Jereb M, Muzlovic I, Prabhu RM. Clinical review: Severe malaria. Crit Care. 2003;7: 315–323. doi:10.1186/cc2183
    OpenUrlCrossRefPubMedWeb of Science
  91. 91.↵
    Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature. 2015;517: 327–332. doi:10.1038/nature139942
    OpenUrlCrossRefPubMed
  92. 92.↵
    Michalopoulos S. The Origins of Ethnolinguistic Diversity Am. Econom Rev. 2012,. 2012;102: 1508–1539.
    OpenUrl
  93. 93.↵
    Guerini D, Pan B, Carafoli E. Expression, purification, and characterization of isoform 1 of the plasma membrane Ca2+ pump. Focus on calpain sensitivity. J Biol Chem. 2003;278: 38141–38148. doi:10.1074/jbc.M302400200
    OpenUrlAbstract/FREE Full Text
  94. 94.↵
    Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. 2010;38: 1–7. doi:10.1093/nar/gkq603
    OpenUrlCrossRefPubMed
  95. 95.↵
    Kircher M, Witten DM, Jain P, Roak BJO, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nucl Ac Res,. 2014; doi:10.1038/ng.2892
    OpenUrlCrossRefPubMed
  96. 96.↵
    Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genom Res. 2012; 1790–1797. doi:10.1101/gr.137323.112.
    OpenUrlAbstract/FREE Full Text
  97. 97.↵
    Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Method. 2012;10:1–2
    OpenUrl
  98. 98.↵
    Li M, Santpere G, Kawasawa YI,Evgrafov OV, Gulden FO, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science. 2018; doi:10.1126/science.aat7615
    OpenUrlAbstract/FREE Full Text
  99. 99.↵
    Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat.Neuroscience. 2014; doi:10.1038/nn.3801
    OpenUrlCrossRefPubMed
  100. 100.↵
    Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AL, White BM, Zapardiel-Gonzalo J, et al. Impact of Genetic Polymorphisms on Human Immune Resource Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression. Cell. 2018; 1701–1715.
  101. 101.↵
    Võsa U, Claringbould A, Westra H, Bonder MJ, Zeng B, Kirsten H, et al. Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis. bioRxiv 2018; 1–57. doi: https://doi.org/10.1101/447367. this
  102. 102.↵
    Zhernakova D V, Deelen P, Vermaat M, Iterson M Van, Galen M Van, Arindrarto W, et al. Identification of context-dependent expression quantitative trait loci in whole blood. Blood. 2016; doi:10.1038/ng.3737
    OpenUrlCrossRefPubMed
  103. 103.↵
    Wijst MGP Van Der, Brugge H, Vries DH De, Deelen P, Swertz MA. Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs. Nat.Genet. 2018. 50:493–497; https://doi.org/10.1038/s41588-018-0089-9
    OpenUrlCrossRefPubMed
  104. 104.↵
    Schmitt AD, Hu M, Jung I, Lin Y, Barr CL. A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome. Cell. 2016; 2042–2059.
  105. 105.↵
    Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, et al. Gene expression imputation across multiple brain Regions provides insights into schizophrenia risk. Nat.Genet. 2019; 51: 659–674 https://doi.org/10.1038/s41588-019-0364-4
    OpenUrlCrossRefPubMed
  106. 106.↵
    Andersson R, Gebhard C, Miguel-escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014.504:455–461 doi:10.1038/nature12787
    OpenUrlCrossRefPubMed
  107. 107.↵
    Kutmon M, Riutta A, Nunes N, Hanspers K, Willighagen EL, Bohler A, et al. WikiPathways: capturing the full diversity of pathway knowledge. 2016; Nucl.Ac.Res. 44: 488–494. doi:10.1093/nar/gkv1024
    OpenUrlCrossRef
  108. 108.↵
    The 1000 Genomes Project Consortium. Europe A map of human genome variation from population scale sequencing. Nature. 2011;467: 1061–1073. doi:10.1038/nature09534.A
    OpenUrlCrossRefWeb of Science
  109. 109.↵
    Mostafavi S, Ray D, Warde-farley D, Grouios C, Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Nucl.Ac.Res. 2008;9: 1–15.
    OpenUrl
  110. 110.↵
    Hagberg AA, National LA, Alamos L. Exploring Network Structure, Dynamics, and Function using NetworkX. Proc. SciPy. 2008; 11–15.
  111. 111.↵
    Csardi G, Tam’as N. The igraph software package for complex network research. IJCS.
  112. 112.↵
    Deelen P, Bonder MJ, Velde KJ Van Der, Westra H, Winder E, Hendriksen D, et al. Genotype harmonizer: automatic strand alignment and format conversion for genotype data integration. BMC.Res.Not. 2014; 1–4.
  113. 113.↵
    Delaneau O, Marchini J, Zagury J. High-resolution whole-genome haplotyping using limited seed data. Nat.Method. 2013;9.
  114. 114.↵
    Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5. doi:10.1371/journal.pgen.1000529
    OpenUrlCrossRefPubMed
  115. 115.↵
    Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet. 2007;81: 559–575. doi:10.1086/519795
    OpenUrlCrossRefPubMed
  116. 116.↵
    Marees AT, Stringer S, Claire M, Derks EM. A tutorial on conducting genome wide-association studies: Quality control and statistical analysis. Int J Methods Psychiatr Res. 2018; 1–10. doi:10.1002/mpr.1608
    OpenUrlCrossRefPubMed
  117. 117.↵
    Patterson N, Price AL, Reich D. Population Structure and Eigenanalysis. PloS Genet. 2006.2. doi:10.1371/journal.pgen.0020190
    OpenUrlCrossRefPubMed
Back to top
Posted August 17, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Functional analysis of genome-wide dataset from 17000 individuals identifies multiple candidate malaria resistance genes enriched in malaria pathogenic pathways
Delesa Damena, Francis Agamah, Peter O. Kimathi, Ntumba E. Kabongo, Hundaol Girma, Wonderful T. Choga, Lemu Golassa, Emile R. Chimusa
medRxiv 2020.08.15.20175471; doi: https://doi.org/10.1101/2020.08.15.20175471
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area